CONCLUSION
Minimally invasive techniques, which are successfully performed thanks
to technological developments, are becoming more and more common.
Robotic surgery systems have emerged as a potential facilitating factor
for mitral valve surgery procedures. Nowadays, robotic mitral valve
surgery has an important place in clinical practice in today’s
technology. Proper patient selection is important in robotic heart
surgery. In cases such as the presence of severe peripheral vascular
disease, chest deformities such as pectus excavatus where adequate
exposure cannot be provided, severe aortic insufficiency, ascending
aortic aneurysm or atherosclerotic plaques in the ascending aorta,
having advanced lungs attached to the thorax due to previous operations
needs to be well evaluated.
When the results are evaluated as a whole, robotic mitral valve
replacement surgery is an effective and reliable method due to the lower
drainage and less need for blood transfusion compared to conventional
methods, shorter ventilation time, intensive care and hospital stay.
Despite the disadvantages of longer total perfusion and cross clamp
times and technical equipment and trained personnel that require
additional costs for operating theaters, it is an increasingly
successful treatment method due to its early mobilization, faster
recovery, better cosmetic result and increased quality of life compared
to conventional methods. Our results, which are compatible with similar
studies in the literature, show that the importance of robotic mitral
valve surgery will continue to increase and become widespread. Thanks to
the promising postoperative results of robotic surgery, we think that
surgery will take its place in routine clinical applications in the
future with technological developments.